Practitioner Network and Services
The Practitioner Network and Services (PNS) functions to provide the necessary infrastructure to support mental healthcare professionals as they venture to adopt psychedelic medicines into their practices.
Challenges that Inspired Our Solution
Our Practitioner Network and Services (PNS) was conceived as a suite of support services for licensed healthcare professionals interested in psychedelic medicine as they go through the process of incorporating psychedelic-assisted therapy in their practice.
Our goal is to make psychedelic-assisted therapy accessible to as many Canadians as possible. Our action, in support of this goal, and through this suite of services, is to build capacity for regulated healthcare professionals to provide care ethically and safely.
Introduction to Psychedelic-assisted Therapy Training Program
Psilocybin-assisted Therapy Training Program, including the experiential practicum (firsthand experience with psilocybin, as well as guiding others through psilocybin journeys).
Practitioner Network and Services (PNS) - collaborate with a network of mental health professionals.
Practitioner Network and Services (PNS)
We recognize the limited time and resources at your disposal; as such, we provide a turn-key solution to help you integrate psychedelic-assisted therapy effortlessly into your practice. Health professionals who achieve competency in this area will be able to adopt the treatment without any disruptions to the current services they provide.
The PNS will allow psychologists, accredited and certified counselors, and other mental health professionals across Canada to seamlessly integrate psychedelic-assisted therapy into clinics and independent practices, with the confidence that it is done at the highest level of professionalism and integrity.
The Practitioner Network and Services on our Platform
Our Practitioner Network and Services will be accessible on a user-friendly, robust
digital platform, which will serve as a central hub for all services required to integrate psychedelic-assisted therapy into your practice. The platform will allow for participating therapists to exchange data, experiences, and discoveries, as well as to facilitate group discussions, thus helping to improve the practice of psychedelic therapy, and providing access to resources crucial in guiding you to competently deliver this treatment.
The platform will include a client access interface, which will provide clients with mental wellness resources, and it will also act as a directory where they can seek, be referred to, and connect with practitioners near them who providing psychedelic-assisted therapy.
In-depth knowledge of psychedelic-assisted therapy
Experiential Training Through Clinical Trials
Psychedelic-assisted Therapy Practice Knowledge
Through Health Canada-approved clinical trials, ATMA offers practitioners the opportunity to gain firsthand experience with psychedelic medicine in a safe space; an additional component of this experience will involve guiding peers through psychedelic journeys, allowing for practitioners to gain a comprehensive understanding from multiple perspectives.
Clinical trials provide an avenue for practitioners to gain an in-depth knowledge of psychedelic-assisted therapy, from preparation of the client through to post-integration psychotherapy. The clinical trials will operate in conjunction with ATMA’s Psilocybin-assisted Therapy Training Program.